Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlliance Pharma Regulatory News (APH)

  • This share is currently suspended. It was suspended at a price of 64.70
  • There is currently no data for APH

Form 8.5 (EPT/RI)-Alliance Pharma plc

13 Jan 2025 09:02

Form 8.5 (EPT/RI)-Alliance Pharma plc

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Name of exempt principal trader:Investec Bank plc
(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeAlliance Pharma plc
(c) Name of the party to the offer with which exempt principal trader is connected:Investec is financial advisor to Aegros Bidco Limited (a newly incorporated company indirectly owned by DBAY Affiliates and the ERES IV Fund)
(d) Date dealing undertaken:10th January 2024
(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible cash offer, state “N/A”N/A

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchases/ sales Total number of securitiesHighest price per unit paid/receivedLowest price per unit paid/received
Ordinary sharesPurchases3,631,97261.260.8
Ordinary sharesSales3,679,32061.361

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
N/AN/AN/AN/AN/A

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
N/AN/AN/AN/AN/AN/AN/AN/A

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
N/AN/AN/AN/AN/A

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
N/AN/AN/AN/A

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

Date of disclosure:13th January 2025
Contact name:Priyali Bhattacharjee
Telephone number:+91 9768034903

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
1st Jul 20204:42 pmRNSTotal Voting Rights
1st Jul 20204:39 pmRNSBlock Listing Six Monthly Return
26th Jun 20206:14 pmRNSDirector Share Purchases
2nd Jun 20203:33 pmRNSNotification of Major Holdings
1st Jun 202011:06 amRNSTotal Voting Rights
29th May 20205:21 pmRNSNotification of Major Holdings
18th May 20202:43 pmRNSResult of AGM
18th May 20207:00 amRNSAGM Statement
11th May 20203:44 pmRNSDirector’s Dealing
1st May 202011:47 amRNSTotal Voting Rights
22nd Apr 20205:00 pmRNSAnnual Report and Notice of AGM
8th Apr 20207:00 amRNSBlock Admission Application
7th Apr 20207:00 amRNSFull Year Results 2019
2nd Apr 20203:53 pmRNSTotal Voting Rights
30th Mar 20207:00 amRNSNotification of Preliminary Results & Analyst Call
23rd Mar 20203:52 pmRNSFCA Moratorium on Publication of Results
3rd Mar 202012:54 pmRNSTotal Voting Rights
4th Feb 20204:45 pmRNSNOTIFICATION OF MAJOR HOLDINGS
3rd Feb 20205:13 pmRNSTotal Voting Rights
22nd Jan 202012:04 pmRNSNotification of Major Holdings
22nd Jan 20207:00 amRNSFull Year Trading Update
6th Jan 20201:58 pmRNSBlock Listing Six Monthly Return
3rd Jan 20207:00 amRNSTotal Voting Rights
2nd Jan 20204:38 pmRNSNOTIFICATION OF MAJOR HOLDINGS
6th Dec 20194:42 pmRNSGrant of Options to Directors
5th Dec 20195:17 pmRNSNotification of Major Holdings
5th Dec 20193:00 pmRNSDirector's Dealing
3rd Dec 201912:07 pmRNSTotal Voting Rights
27th Nov 20197:00 amRNSReturn of Xonvea Licensing Rights
5th Nov 20193:51 pmRNSTotal Voting Rights
9th Oct 201911:14 amRNSDirector's Dealing
3rd Oct 20197:00 amRNSTotal Voting Rights
24th Sep 20197:00 amRNSInterim Results
3rd Sep 20193:26 pmRNSTotal Voting Rights
5th Aug 20197:00 amRNSNotification of Interim Results
2nd Aug 201910:04 amRNSTotal Voting Rights
17th Jul 20197:00 amRNSHalf Year Trading Update
1st Jul 201912:39 pmRNSTotal Voting Rights
1st Jul 20198:00 amRNSBlock Listing Six Monthly Return
1st Jul 20197:00 amRNSDirectorate Change
4th Jun 201911:58 amRNSTotal Voting Rights
23rd May 201910:30 amRNSResult of 2019 AGM
23rd May 20197:15 amRNSAGM Statement
23rd May 20197:15 amRNSComment on CMA Statement of Objections
1st May 20193:53 pmRNSTotal Voting Rights
16th Apr 201912:05 pmRNSAnnual Report and Notice of AGM
10th Apr 20197:00 amRNSMarketing Authorisation for Xonvea in Ireland
26th Mar 20197:00 amRNSFull Year Results
26th Feb 20197:00 amRNSNotification of Preliminary Results
4th Feb 20193:40 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.